Topiramate Tablet, Film Coated
Product Images NDC 68788-7351

4 FDA label images from Preferred Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68788-7351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 01

7ea951b6 B020 481f 8acc 12fb7a3a69fd 01
Chemical structure of sacrosidase as depicted in the image, showing its molecular configuration with multiple oxygen and carbon atoms, including functional groups like ether and sulfonamide.*
FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 02

7ea951b6 B020 481f 8acc 12fb7a3a69fd 02
A Kaplan-Meier curve showing cumulative rates for time to first seizure over 500 days comparing topiramate 50 mg/day and 400 mg/day. The y-axis represents cumulative event rates, and the x-axis is time in days. Two curves are shown: a solid line for 50 mg/day and a dashed line for 400 mg/day. The graph includes a p-value of 0.0002, indicating a statistically significant difference between the two groups.*
FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 03

7ea951b6 B020 481f 8acc 12fb7a3a69fd 03
A bar chart displaying changes from baseline to double-blind phase in average monthly migraine period rate (±SE) for placebo and three doses of topiramate (50 mg/day, 100 mg/day, 200 mg/day). Data is shown for two studies (Study 11 and Study 12) with participant numbers indicated. The chart includes significance markers for some topiramate doses.*
FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 05

7ea951b6 B020 481f 8acc 12fb7a3a69fd 05
Label for Topiramate Tablets USP 50 mg, film-coated tablets for oral use, generic for Topamax. Each tablet contains 50 mg topiramate. The label shows the product is manufactured by Zydus Pharmaceuticals USA Inc. and labeled by Preferred Pharmaceuticals Inc. Includes directions for use in English and Spanish, storage instructions, and a caution about federal drug transfer laws.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.